Article
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.
Antimicrobial agents and chemotherapy - 1 Jun 2008
Cleary John D, Garcia-Effron Guillermo, Chapman Stanley W, Perlin David S
Abstract excerpt
We describe a case of recurring Candida glabrata infection in a 68-year-old African-American female on caspofungin therapy. The initial isolate was susceptible, but isolates recovered during following relapses were not. All isolates were clonal, and high-MIC strains contained a mutation in the highly conserved hot spot 1 region of Fks1p.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
